Inflammation

The FDA accepted an investigational new drug application for a trispecific fusion antibody for the treatment of diabetic macular edema, according to a press release from Eluminex Biosciences.

Black adolescents who face more racial discrimination may be more likely to have metabolic syndrome at age 31 years, according to findings published in JAMA Network Open.

Once-daily consumption of a supplement of lutein, zeaxanthin isomers, curcumin and vitamin D3 improved tear production and reduced ocular surface damage, inflammation and patient-reported symptoms in dry eye disease, according to research.

BOSTON — In this Healio Video Perspective from the ASCRS meeting, Steven M. Silverstein, MD, FACS, ABO, discusses IRIS Registry data related to Dextenza.

Ocugen has announced that dosing is complete in the second cohort of its phase 1/2 ArMaDa clinical trial to assess the safety of OCU410, a modifier gene therapy candidate for geographic atrophy.

A personalized cancer vaccine produced T-cell responses in certain patients with head and neck squamous cell carcinoma, according to results from a randomized study presented at American Association for Cancer Research Annual Meeting.

SAN DIEGO — In this Healio video perspective from the American Academy of Dermatology Annual Meeting, Alphyn Biologics CEO Neal Koller discusses new data from the company’s phase 2a trial of AB-101a for the treatment of atopic dermatitis.

TAMPA, Fla. — In a presentation from Telling It Like It Is, María H. Berrocal, MD, FASRS, uses surgical footage to showcase techniques for repositioning an IOL, including in patients with uveitis-glaucoma-hyphema syndrome.

Researchers in Kentucky identified mechanisms by which heat exposure caused immune response that may increase inflammation.

SAN DIEGO — Modulation of psoriasis biomarkers and pathways were observed in patients who experienced clinical success with TAK-279, according to phase 2b trial results.